Welcome to our dedicated page for Covista SEC filings (Ticker: CVSA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Covista Inc. filings document current reports on operating results, academic performance, investor communications and strategic progress for its healthcare education portfolio. Recent Form 8-K records furnish quarterly results releases, enrollment metrics, revenue and earnings measures, fiscal guidance, share repurchase activity, debt refinancing references and institutional updates for Chamberlain and Walden.
The company's Regulation FD disclosures also include investor newsletters describing milestones, partnerships, workforce-related initiatives and operational progress. Covista's filing record identifies public-company disclosure themes tied to results of operations, capital allocation, governance signatories, cautionary forward-looking statements and the company's current identity as a NYSE-listed healthcare educator.
Covista Inc. (CVSA) is the issuer of common stock for which a notice of proposed sale has been filed under Rule 144 by officer Manjunath Gangadharan. The filing lists a proposed sale of 1,802 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $248,279.56 and a proposed sale date of August 27, 2026 on the NYSE. The shares are reported as having been acquired on August 23, 2026 via Performance Stock Units.
Covista Inc. (CVSA) reported insider equity activity for officer Michael Betz (Pres. Walden University & CDO). On 2026-08-23 he received 7,320 and 5,124 shares of common stock as payouts of performance share units awarded on November 8, 2023, at a reference price of $132.35 per share. On the same date, 945, 3,302, and 2,311 shares were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and performance shares.
Covista Inc. (CVSA) reported that Chief Financial Officer Phelan Robert J. had equity compensation activity in the company’s common stock on August 23, 2026. He received two share awards totaling 7,056 and 10,080 shares as payouts of performance share units granted on November 8, 2023, at a reference price of $132.35 per share. In related transactions, 1,279, 3,126, and 4,466 shares were delivered or withheld to satisfy tax withholding obligations upon the vesting of previously awarded restricted stock units and performance shares.
Covista Inc. (CVSA) reported that Gangadharan Manjunath, VP and Chief Accounting Officer, had equity compensation vest on August 23, 2026. He received 1,050 shares of common stock as payout of performance share units awarded on November 8, 2023, and 1,500 shares in connection with vested performance shares.
To cover related tax withholding obligations upon vesting of these restricted stock units and performance shares, a total of 936 common shares were disposed of through share withholding at a reference value of $132.35 per share. All transactions involve directly held common stock and are compensation-related rather than open‑market trades.
Covista Inc. (CVSA) reported insider equity compensation activity by Douglas G. Beck, SVP, GC, Corp. Sec & ISS. On 2026-08-23 he received two Common Stock awards of 4,242 and 6,060 shares at a reference price of $132.35 per share in payout of performance share units awarded on November 8, 2023. On the same date, a total of 5,452 shares of Common Stock were withheld at $132.35 per share to satisfy tax withholding obligations related to the vesting of previously awarded restricted stock units and performance shares. These are compensation-related grants and tax-withholding dispositions, not open-market purchases or sales.
Covista Inc. (CVSA) reported Form 4 transactions by Chairman & CEO Stephen W. Beard involving equity awards and related tax withholding in Covista common stock on August 23, 2026. Beard received two acquisitions coded "A" totaling grants of common stock issued in payout of performance share units that had been awarded on November 8, 2023, at a reference price of $132.35 per share. Three dispositions coded "F" reflect shares delivered or withheld to satisfy tax withholding obligations upon the vesting of previously awarded restricted stock units and of the performance shares, also valued at $132.35 per share. All transactions are recorded as direct holdings, and the filing describes the F-code entries as payments of tax liability by delivering or withholding securities.
Covista Inc. (CVSA) reported that Leslie Storms has become a director and filed an initial statement of beneficial ownership on Form 3. The filing does not list any reportable holdings or derivative positions for Storms as of the reporting date.
Covista Inc. (CVSA) filed an initial ownership report for Emily C. Chiu, who is identified as a director of the company. The Form 3 shows no reportable transactions or holdings of Covista securities at the time of this filing, based on the provided data.
Covista Inc.’s Chairman & CEO Stephen W. Beard reported a sale of 3,545 shares of Common Stock on August 11, 2026 at a weighted average price of $130.345 per share, executed in multiple trades between $130.005 and $131.343. The sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on December 10, 2025 pursuant to Covista’s insider trading policies, which state that no discretionary trades are permitted absent a hardship exception. Following this transaction, Beard held 415,197 shares directly.
Covista Inc. (CVSA) has a planned sale of Covista common stock by the Stephen Wayne Beard Trust u/a/d 09/03/2015, with Mr. Stephen W. Beard Jr. as trustee. The trust has engaged Goldman Sachs & Co. LLC, 200 West Street, New York, as broker to sell 3,545 shares of Covista common stock on or after 08/11/2026 on the NYSE. These shares were acquired on 09/08/2025 as compensation in the form of Restricted Stock Units.
Over the past three months, the trust has already sold Covista common stock in three transactions: 2,762 shares on 06/10/2026 for $359,443.37, 2,529 shares on 06/11/2026 for $330,754.51, and 5,291 shares on 07/13/2026 for $702,399.30.